Your browser doesn't support javascript.
loading
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.
Weber, Daniela; Jenq, Robert R; Peled, Jonathan U; Taur, Ying; Hiergeist, Andreas; Koestler, Josef; Dettmer, Katja; Weber, Markus; Wolff, Daniel; Hahn, Joachim; Pamer, Eric G; Herr, Wolfgang; Gessner, André; Oefner, Peter J; van den Brink, Marcel R M; Holler, Ernst.
Afiliação
  • Weber D; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany. Electronic address: daniela.weber@ukr.de.
  • Jenq RR; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peled JU; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Taur Y; Department of Medicine, Weill Cornell Medical College, New York, New York; Infectious Diseases Services, Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hiergeist A; Institute of Clinical Microbiology and Hygiene, University Medical Center, Regensburg, Germany.
  • Koestler J; Institute of Clinical Microbiology and Hygiene, University Medical Center, Regensburg, Germany.
  • Dettmer K; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • Weber M; Department of Orthopedic Surgery, University Medical Center, Regensburg, Germany.
  • Wolff D; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany.
  • Hahn J; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany.
  • Pamer EG; Department of Medicine, Weill Cornell Medical College, New York, New York; Infectious Diseases Services, Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Herr W; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany.
  • Gessner A; Institute of Clinical Microbiology and Hygiene, University Medical Center, Regensburg, Germany.
  • Oefner PJ; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • van den Brink MRM; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Holler E; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany.
Biol Blood Marrow Transplant ; 23(5): 845-852, 2017 May.
Article em En | MEDLINE | ID: mdl-28232086
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco / Microbioma Gastrointestinal / Antibacterianos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco / Microbioma Gastrointestinal / Antibacterianos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article